Ascendis Pharma A/S Form 20-F: Annual report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-02-11: Form 20-F; Period of report 2025-12-31; Description 20-F; Document asnd-20251231.htm.
- 2025-02-12: Form 20-F; Period of report 2024-12-31; Description 20-F; Document asnd-20241231.htm.
- 2024-02-07: Form 20-F; Period of report 2023-12-31; Description 20-F; Document asnd-20231231.htm.
- 2023-02-16: Form 20-F; Period of report 2022-12-31; Description 20-F; Document asnd-20221231.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-02-11 | 20-F | 2025-12-31 | 20-F | asnd-20251231.htm |
| 2025-02-12 | 20-F | 2024-12-31 | 20-F | asnd-20241231.htm |
| 2024-02-07 | 20-F | 2023-12-31 | 20-F | asnd-20231231.htm |
| 2023-02-16 | 20-F | 2022-12-31 | 20-F | asnd-20221231.htm |
| 2022-03-02 | 20-F | 2021-12-31 | FORM 20-F | d232088d20f.htm |
| 2021-03-10 | 20-F | 2020-12-31 | 20-F | d123790d20f.htm |
| 2020-04-03 | 20-F | 2019-12-31 | 20-F | d841629d20f.htm |
| 2019-04-03 | 20-F | 2018-12-31 | FORM 20-F | d654369d20f.htm |
| 2018-03-28 | 20-F | 2017-12-31 | FORM 20-F | d445343d20f.htm |
| 2017-03-22 | 20-F | 2016-12-31 | FORM 20-F | d364020d20f.htm |
| 2016-04-15 | 20-F | 2015-12-31 | FORM 20-F | d163051d20f.htm |
| 2015-03-26 | 20-F | 2014-12-31 | FORM 20-F | d892830d20f.htm |